IMVIF — Imv Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $7.67m
- $0.33m
Annual income statement for Imv, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.373 | 0.428 | 0.225 | 0.188 | 0.329 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16.1 | 20.1 | 26.3 | 35.9 | 38.5 |
| Operating Profit | -15.7 | -19.7 | -26 | -35.7 | -38.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -16.9 | -20.6 | -26.1 | -36.6 | -38 |
| Net Income After Taxes | -16.9 | -20.6 | -26.1 | -36.6 | -38 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16.9 | -20.6 | -26.1 | -36.6 | -38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16.9 | -20.6 | -26.1 | -36.6 | -38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.87 | -4.15 | -5.15 | -5.37 | -4.77 |